Status:
UNKNOWN
Muscle Mass and Strength as Predictors of Time to Discharge in Patients With COVID-19
Lead Sponsor:
University of Sao Paulo
Conditions:
SARS-CoV 2
Eligibility:
All Genders
18+ years
Brief Summary
The severe acute respiratory syndrome induced by the new coronavirus (SARS-CoV-2) has been declared a worldwide pandemic. Identifying common characteristics of the disease is crucial to promote a bett...
Detailed Description
Muscle mass (via ultrasound) and muscle strength (via handgrip) of patients with SARS-CoV-2 will be assessed upon admission, medical discharge and 180 days after medical discharge. The time until medi...
Eligibility Criteria
Inclusion
- 18 Years and older ;
- hospital stay less than 48 hours;
- length of hospital stay to 48 hours no requiring invasive mechanical ventilation;
Exclusion
- cancer in the last 5 years;
- delirium;
- cognitive deficit that impossibility the patient to read and sign the informed consent form;
- neurological disease;
- degenerative muscular disease.
Key Trial Info
Start Date :
May 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 23 2022
Estimated Enrollment :
176 Patients enrolled
Trial Details
Trial ID
NCT04406233
Start Date
May 23 2020
End Date
May 23 2022
Last Update
May 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Univsersity of Sao Paulo
São Paulo, Brazil, 05508-030